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Histaminase is a specific amine oxidase that deaminates histamine and may 
be  distinguished from  the  diamine oxidases  that  catabolize  putrescine  and 
cadaverine (1). Histaminase and histamine methyltransferase are the principal, 
if not the only, enzymes that degrade histamine in man  (2), although their 
relative functional and physiologic importance is uncertain. A histamine-catab- 
olizing enzyme system with physicochemical and functional characteristics of 
authentic histaminase is found in the granule-rich fraction of human neutro- 
phils and eosinophils; while histamine methyltransferase is in the cell sap of 
human monocytes (3). 
Intact viable polymorphonuclear  leukocytes and monocytes exposed in vitro to 
phagocytic and several other stimuli, release granule-associated lysosomal en- 
zymes (beta glucuronidase, myeloperoxidase, and acid phosphatase (4,  5) and 
nonlysosomal enzymes such as  lysozyme (4)  and collagenase  (6). Lysosomal 
enzyme release  occurs by  exocytosis,  whereby the  granular  membrane and 
plasma membrane fuse and the contents of the secretory granule are discharged 
extracellularly (7). Lysosomal enzyme release from granulocytes and histamine 
release from mast cells and basophils have been shown to be modulated by 
intracellular levels of cyclic nucleotides (8, 9), metabolic inhibitors (10, 11), and 
by agents that disrupt or promote aggregation of microtubules (10, 11). 
Particles phagocytized by leukocytes, including zymosan coated with comple- 
ment (4), latex particles bound with IgG (12), aggregated IgG (13), and antigen 
antibody complexes (4, 12) induce release of lysosomal enzymes. The secretory 
phase of granulocyte enzyme release may be isolated from phagocytosis and 
analyzed separately with the use of cytochalasin B (CB) 1 (14) or calcium iono- 
phore  (15). CB  prevents phagocytosis but facilitates the secretory release of 
lysosomal enzymes from granulocytes (10, 13). The calcium ionophore A-23187 
binds  to  cell  membranes and  chelates  calcium,  thereby promoting calcium 
influx (16) which may account for its capacity to induce secretion of hormones 
* Supported by U. S. Public Health Service grant no. AI 11419  and grants from the Hoed 
Foundation, Dooner Laboratories, and the Ina Sue Perlmutter Research Fund. 
Recipient of U. S. Public Health Service special  fellowship AI 57387 and is a Charles A. 
Janeway Scholar in Pediatric  Medicine. 
§ Supported by U. S. Public Health Service training grant AI 00366. 
II  Recipient of  U. S. Public Health Service Research Career Development Award no. HD70558. 
i  Abbreviations used in this  paper: CB, cytochalasin B; DMSO, dimethylsulfoxide; LDH, lactic 
dehydrogenase; KI, concentration of  inhibitor  required for  50% inhibition  of  histamine release. 
THE  JOURNAL  OF EXPERIMENTAL  MEDICINE  • VOLUME  144, 1976  1049 1050  HISTAMINASE  RELEASE  FROM  HUMAN  GRANULOCYTES 
(insulin) (17), enzymes (amylase) (18), and mediators (histamine, ECF-A) (19, 
20). Lysosomal enzymes apparently are released minimally by ionophore (5). 
In this report evidence is presented that opsonized zymosan or the calcium 
ionophore A-23187 induced the release of histaminase from normal and CB- 
treated human granulocytes. Release was specific,  noncytotoxic, dose depend- 
ent, and suppressed by metabolic inhibitors and colchicine. 
Materials and Methods 
Materials.  The following were purchased: Saccharomyces cerevisiae yeast (zymosan A) (Sigma 
Chemical Co., St. Louis, Mo.), calcium ionophore A-23187 (Eli Lilly & Co., Indianapolis, Ind.), and 
CB (I.D.I. Macclesfield, Cheshire, England). CB and calcium ionophore were dissolved in dimeth- 
ylsulfoxide  (DMSO)  and  diluted  for use  (final  maximal  concentration  of DMSO,  0.5%).  This 
concentration of DMSO when added to control cells did not alter cell morphology or affect enzyme 
release  or  measurement.  Phenolphthalein  glucuronic  acid  (Sigma  Chemical  Co.),  histamine 
dihydrochloride (Sigma Chemical Co.),  iodoacetamide (Sigma Chemical Co.),  colchicine (Sigma 
Chemical Co.),  lanthanum chloride (Sigma Chemical Co.),  sodium azide  (Fisher Scientific Co., 
Fairlawn,  N.  J.),  2-deoxy-v-glucose  (Pfansteihl  Labs.,  Inc.,  Waukegan,  Ill.),  aminoguanidine 
(Eastman Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.), Hypaque (Winthrop 
Laboratories, New York), and Ficoll (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), were 
obtained  in  reagent  grade.  The  Tris  buffer  used  was  0.025  M  Tris,  pH  7.35,  at  37°C  (Sigma 
Chemical Co.),  0.12 M  sodium chloride, 0.005 M  potassium chloride, and 0.3 mg/ml human salt- 
poor serum albumin (Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif.). This consti- 
tutes Tris-A; Tris ACM contains, in addition, calcium at 0.6 mM and magnesium at 1.0 mM (21). 
Ring  12-~4C]histamine  (58  mCi/mmol)  (Ameraham/Searle  Corp.,  Arlington  Heights,  Ill.)  was 
repurified by thin-layer chromatography (22). 
Methods 
PaEPARXTION OF LEUKOCYTES.  20 ml of peripheral blood anti-coagulatod with sodium  EDTA 
(final concentration 5 x  10 -'~ M) was diluted with an equal volume ofTris A buffer and centrifuged 
at 400 g  for 30 rain  and  10°C on a  15 ml cushion of Ficoll-Hypaque  (23).  Purified granulocyte 
suspensions (<2% mononuclear cells) were separated from erythrocytes in the pellet by one to two 
cycles of hypotonic lysis (3). Mononuclear cells (< 1% granulocytes) containing basophils, lympho- 
cytes, and monocytes,  were obtained from the interface of the gradient and used for histamine- 
release experiments. 
CELL INCUBATION  AND ENZYME-RELEASE  PROCEDURES.  Leukocyte suspensions containing 0.5- 
1.0 ×  107 cells ~n 0.10 ml Tris ACM  .were mixed with varying concentrations of zymosan  and 
calcium ionophore in a final vol of 0.125 ml. Incubation was performed for 30 rain at 37°C with 
intermittent shaking. The reaction was stopped by rapid cooling to 0°C followed by pelleting the 
cells at 600 g for 10 min at 4°C. The supernatant solutions were decanted, frozen at -90°C, and 
later used for enzyme and histamine determinations.  Control buffer blanks were used in each 
experiment. 
VIABXLITV OF C~.LLS.  Cell viability at the end of each experiment was assessed by either trypan 
blue exclusion (Grand Island Biological Co., Grand Island, N. Y.) or lactic dehydrogenase (LDH) 
release (24).  Only experiments in which greater than 90% of the cells remained viable by these 
criteria are reported. 
O~aONIZAWON OF ZVMOSAN.  Opsonized zymosan was generated by incubating 10 mg of boiled 
washed zymosan with 1 ml fresh serum from the leukocyte donor for 30 min at 37°C. The opaonized 
zymosan  was  washed  (five  times)  in  Tris  buffer  to  remove  nonadherent serum  components. 
Zymosan to cell ratio varied from 0.25 to 3.0 particles per cell depending on the experimental 
design. 
ENZYME  ASSAYS.  Histaminase was determined by radioenzyme assay as described previously 
(22). Briefly,  37.5 ng (2.5/El)  repurified ring {2-~4C]histamine  were added to 25 ~I of  supernate or 
cell  lysate and the mixture incubated at  37°C for  5 h. The reaction was terminated by the addition 
of  a 2.5 ~l solution containing aminoguanidine  (10  -a M) and imidazole acetic acid (0.75 mg/ml). 
For background  control the aminoguanidine  solution  was added to the supernates before the 
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were  then  chromatographed  10  cm  on  cellulose  chromatogram  plastic  back  sheets  (Eastman 
Kodak Co., Rochester, N. Y.) using butanol:concentrated acetic acid:water (4:1:1) as solvent. The 
area containing histamine degradation products was cut and its radioactivity measured by scintil- 
lation spectrometry. 
Beta glucuronidase was determined on 50 ~1 of the reaction supernatant solution or 30 ~1 of the 
cell lysate with phenolphthalein glucuronic acid as substrate (0.002 M  final concentration) and 
incubated for 18 h  at 37°C using the method of Talay et al.  (25).  LDH was determined using the 
Dade UV-10-LDH kit (Dade Div., American Hospital Supply Corp., Miami,  Fla.) by a  modified 
Wacker method  (26)  using a  Unicam SP 800 A  spectrophotometer  (Unicam Instruments Ltd., 
Cambridge, England) at 340 nm. 
The total enzyme content (completes) was measured on the supernatant solution obtained after 
incubating  400  ~I  of  untreated  cell  suspensions in  i0  ~g/ml  calcium  ionophore or  0.1%  Triton  X-100 
(Packard Instrument Co.,  Inc.,  Downers Grove, Ill.)  for histaminase and only Triton for beta 
glucuronidase and  LDH determination. Incubation time  was  30  rain  at  37°C  followed  by  five  freeze- 
thaw cycles.  Cell  debris was removed by centrifugation  at 10,000  g for  5 min at 4°C.  Duplicate 
enzyme assay varied by no more than 10%. The sum of  residual  cellular  enzyme activity  and 
release  enzyme activity  approached 100%. 
HISTAMINe- ASSAY.  Leukocyte  histamine  was  determined  by  the  method of  May et  al. (27).  The 
total  histamine  content was estimated  on a portion  of  the cells  after  boiling. 
Results 
Zymosan-Induced Histaminase Release from Human Granulocytes.  Purified 
human  granulocytes were incubated with varying concentrations  of opsonized 
zymosan  for  30  rain  at  37°C  2 and  the  histaminase  and  beta  glucuronidase 
released into the medium were determined.  Enzyme release was a  function of 
zymosan concentration from 0.25 to 3.0 particles per cell (Fig.  1). The highest 
particle concentration released virtually all the cellular histaminase while only 
releasing  20%  of the  beta  glucuronidase  (Fig.  1).  In  other  experiments  the 
maximum  histaminase  released by three  particles per cell varied from 60  to 
100% depending  on the granulocyte preparation;  moreover,  the percentage  of 
histaminase released was characteristically  at least four to five times greater 
than  that  of beta glucuronidase.  Histaminase  release  was maximal  at  37°C, 
completely prevented at 4°C,  and was only 5 and 30% of maximal  at 20°C and 
30°C, respectively. Release occurred without the concomitant release of LDH or 
the uptake of trypan blue, indicating a  noncytotoxic release of the enzyme. 
Kinetics  of  Zymosan-Induced  Histaminase  Release.  Granulocytes  pre- 
warmed  to  37°C  were mixed  with  opsonized zymosan,  the  reaction  mixtures 
were rapidly cooled to 0°C at timed intervals, and the cells pelleted by centrifu- 
gation.  Preliminary  experiments  indicated that this procedure prevented fur- 
ther  enzyme release.  As  shown in  Fig.  2,  histaminase  release began  after a 
period of 2-5 min, and was maximal at about 30 rain. A similar time-course was 
noted for beta glucuronidase release, however, at each particle concentration, 
release of this enzyme was only 20-25% that of histaminase release. 
Effect  of  Opsonization  on  Zymosan-Induced  Granulocyte  Histaminase 
Release.  Human granulocytes incubated with opsonized zymosan at a concen- 
tration  of one particle  per cell released 55%  of the total  cellular  histaminase 
content.  Spontaneous release was 13%  (Fig.  3).  Cells incubated with zymosan 
alone  or  with  zymosan  pretreated  with  heat-inactivated  serum  (56°C,  1  h) 
released significantly less histaminase than cells exposed to opsonized particles. 
2 These conditions were chosen on the basis of the kinetic experiments described below. 1052  HISTAMINASE  RELEASE  FROM  HUMAN  GRANULOCYTES 
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Fro. i.  Release of  histaminase and fi-glucuronidase  from human granulocytes induced by 
opsonized zymosan: effect  of  particle/cell  ratio.  Each point represents the mean net release 
from duplicate incubation mixtures. Total histaminase activity,  100.6  pmol/h; fl-glucuroni- 
dase, 28.7/~g phenolphthalein/h/0.5  × 107 granulocytes. 
Light microscopy demonstrated that opsonization also potentiated the phagocy- 
tosis ofzymosan particles. Beta glucuronidase release was maximal with opson- 
ized zymosan but total release was less than 10% at the particle to cell concen- 
tration used in these experiments. 
Effect  of Divalent  Cations  on  Histaminase  Release.  The  requirement  of 
divalent cations for opsonized zymosan-induced histaminase release is shown in 
Fig.  4.  Granulocyte  histaminase  release  induced  by opsonized  zymosan  was 
maximal  in  the  presence  of both  calcium  and  magnesium.  Optimal  release 
occurred at a calcium concentration of 0.6 mM and magnesium concentration of 
1.0 mM.  Specific histaminase  release was markedly reduced when either cal- 
cium or magnesium were present alone and was prevented with the absence of 
added  divalent  cations  or in  the  presence  of 1  ×  10  -3  M  EDTA;  lanthanum 
chloride  (10 -4 M),  an  agent  that  interferes  with  calcium  flux  (28),  inhibited 
opsonized zymosan-induced histaminase  release  (Table I).  Beta glucuronidase 
release was similarly dependent on divalent cations but again was less than 10% 
at the particle to cell concentration used. 
Effect of CB on Zymosan-Induced Histaminase Release.  Preliminary exper- 
iments demonstrated that purified human granulocytes preincubated with CB ROBERT  S.  ZEIGER,  FRANK  J.  TWAROG,  AND  HARVEY  R.  COLTEN 
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FIG.  2.  Kinetics of histaminase and fl-glucuronidase release from human granulocytes. 
Zymosan was incubated with granulocytes at 37°C in duplicate and the reaction terminated 
at the indicated times. Total histaminase activity, 111 pmol/h and/3-glucuronidase, 41.5 ~tg 
phenolphthalein/h/0.9 x  107 cells. 
(5 ~g/ml) for 20 min at 20°C failed to phagocytize opsonized zymosan particles 
but did release substantial  quantities  of histaminase.  As presented in Fig.  3, 
granulocytes  pretreated  with  CB  at  concentrations  of 5-10  /~g/ml  and  then 
incubated with opsonized zymosan released nearly 80% of their histaminase,  an 
amount  nearly  twice  that  released  in  the  absence  of CB.  Zymosan-induced 
release  of histaminase  from  CB-treated  granulocytes  was  dependent  on  the 
presence of calcium and magnesium  (Fig.  4).  Beta glucuronidase release was 
also enhanced after CB pretreatment and was dependent on divalent cations, in 
agreement with previous reports (8). 
Calcium  Ionophore.Induced  Histaminase Release from Granulocytes.  Sus- 
pensions  of human  granulocytes  and  mononuclear  cells were each incubated 
with varying concentrations of the ionophore A-23187 for 30 min at 37°C. Release 
of histaminase,  beta glucuronidase, and LDH from granulocytes and histamine 
from the basophil-rich mononuclear cells was then determined.  The extent of 
histaminase release from granulocytes and histamine release from the mononu- 
clear cell fraction were functions of the ionophore concentration  between 0.20 
and 1.0 ~tg/ml (Fig. 5). Ionophore-induced histaminase release was abrogated in E 
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Fro.  3.  Effect  of opsonization  on zymosan-induced  release  of granulocyte  histaminase. 
Boiled zymosan (10 mg) opsonized by incubation with fresh human serum (1 ml) 30 min at 
37°C.  Controls  included  zymosan  plus  heat-inactivated  (56°C,  1 h)  serum  and zymosan 
alone. Each zymosan preparation was added to either CB-pretreated (5 ~g/ml) or untreated 
granulocytes.  Values expressed  as the mean enzyme  released from triplicate  incubation 
mixtures. Total histaminase activity,  140 pmol/h/0.5  x  107 cells. 
the absence of calcium ions.  Lanthanum chloride inhibited ionophore-induced 
release  in dose-dependent fashion  (Table I).  Magnesium was unable to substi- 
tute for calcium. Less than 5% beta glucuronidase and no LDH was released by 
the calcium ionophore even at high ionophore concentrations.  As presented in 
Fig.  6,  the  kinetics  of  calcium  ionophore-induced  granulocyte  histaminase 
release were similar to the kinetics of zymosan-induced release  (Fig.  2). 
Effect of Metabolic Inhibitors and Colchicine  on  Granulocyte Histaminase 
Release.  Aliquots of a granulocyte suspension were preincubated with varying 
concentrations of inhibitor for 15 min at 37°C  and then opsonized zymosan or 
calcium  ionophore  A-23187  were  added.  Controls  consisted  of cells  incubated 
with  the  metabolic  inhibitors  but  without  zymosan  or  ionophore;  and  cells 
incubated in the absence  of the inhibitors but with the appropriate  releasing 
agents.  An identical  experiment was performed except that the effect of meta- 
bolic inhibitors was examined in the presence  of CB  (5  ~zg/ml added with the 
inhibitors).  A  K~  (concentration  of  inhibitor  required  for  50%  inhibition  of 
histaminase  release)  was  calculated  from  the  dose  response  curves  for  each 
inhibiter.  Preliminary experiments indicated that the metabolic inhibitors had 
no effect on the assay for histaminase activity. Deoxyglucose, sodium azide, and 
iodoacetamide  each at concentrations  of 10  -3 M  or less significantly  inhibited 
histaminase release  (Table II). ROBERT  S.  ZEIGER~  FRANK  J.  TWAROG,  AND  HARVEY  R.  COLTEN  1055 
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TABLZ  I 
Inhibition of  Histaminase Release from Human Granulocytes by Lanthanum 
Chloride (LaCl3) * 
Concentration 
of  LaCI~ 
Zymosan induced$  Ionophoreinduced§ 
Release  Inhibition  Release  Inhibition 
M  %  %  %  % 
10 -4  11.5  40  0  100 
10 -5  14.3  26  51.0  43 
10 -e  19.0  0  65.4  27 
10 -7  19.4  0  90.0  0 
None  19.3  90.2 
* Granulocyte suspensions  in  Tris  A buffer  preincubated with LaCl3 for  10  rain  at  4°C 
followed by addition of  calcium (0.6  mM  final  concentration) were then exposed to 
zymosan or ionophore for 30 min at 37°C. Results expressed as the mean release 
from duplicate incubation mixtures. 
Opsonized zymosan (0.5  particle per cell);  total  histaminase activity,  168 pmol/h/ 
0.56 x 107 cells. 
§ Ionophore (0.8/~g/ml);  total  histaminase activity,  107 pmol/h/0.57 x 107 cells. 1056  HISTAMINASE  RELEASE  FROM  HUMAN  GRANULOCYTES 
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Fro.  5.  Ionophore-induced histaminase  and  histamine release. Granulocytes and mono- 
nuclear cells exposed separately to varying concentrations of ionophore at 37°C for 30 rain. 
Enzyme release from the granulocytes and histamine release from the mononuclear cells 
determined in duplicate. Total histaminase activity, 85.4 pmol/h; fl-glucuronidase, 42.5  ~g 
phenolphthalein/h;  and  LDH,  907  Wacker  U/rain  (37°C)/0.8  ×  107  granulocytes.  Total 
histamine content, 0.18  ~g/0.5  x  107 mononuclear cells. 
A  similar experiment designed to test the effect of colchicine on opsonized 
zymosan or ionophore-induced histaminase release demonstrated inhibition of 
release  with K~  of 5  ×  10 -4  M  (Table  II).  Further  evidence  of a  role  for 
microtubules in histaminase release was obtained in an experiment showing a 
30% enhancement of zymosan-induced release in the presence of buffer contain- 
ing heavy water (D20,  44%). 
Discussion 
Equipped with histamine catabolic enzymes (3), human leukocytes possess 
the  potential  to  inactivate histamine at  sites  of inflammation. The  present 
studies were designed to evaluate the capacity of  granulocytes to release histam- 
inase in response to both phagocytic and secretory stimuli. The experiments 
demonstrated that  human granulocytes released  histaminase quantitatively ROBERT  S.  ZEIGER,  FRANK  J.  TWAROG,  AND  HARVEY  R.  COLTEN  1057 
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FIG.  6.  Kinetics of ionophore-induced  histaminase release from human  granulocytes: 
effect  of ionophore concentration. Values expressed as the mean of duplicate incubation 
mixtures. Total histaminase activity,  255 pmol/h/0.75 × 107 cells. 
TABLE  II 
Inhibition of Histaminase Release from Human Granulocytes 
Ionophore in- 
Inhibitor*  Zyrnosan induced§  ducedl  i 
Cells alone  Cells with CB¶  Cells alone 
Iodoacetamide  0.20  0.50  1.00 
2-Deoxyglucose  0.45  > 1.0"*  0.40 
Sodium azide  0.10  ND*~  ND 
Colchicine  0.50  0.50  1.00 
* Inhibitors preincubated with cells for 15 min at 37°C; also present during the 30-min exposure to 
zymosan or ionophore. 
Kt, concentration (raM) yielding 50% inhibition of release. 
§ Opsonized zymosan (1.5 particles per cell) released 51 and 90% granulocyte histaminase from 
normal and CB-treated cells,  respectively. Total histaminase activity, 72.8 pmol/h/0.5  ×  107 
cells. 
II Ionophore (1 ~tg/ml) released 91% of cellular histaminase. Total histaminase activity, 140 pmol/ 
h/1.0  x  107 cells. 
¶ CB (5/zg/ml) preincubated with cells for 15 rain at 37°C. 
** 0-20% inhibition at 1 raM. 
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when incubated in vitro with either opsonized zymosan orthe calcium ionophore 
A-23187. Histaminase release required the presence of divalent cations (both 
calcium and magnesium for optimal release after opsonized  zymosan and cal- 
cium alone for ionophore-induced release). Release was inhibited by EDTA, a 
chelating agent, and by lanthanum chloride, an agent which interferes with 
transmembrane movement of calcium ions (29). 
The necessity of energy generation for histaminase release was indicated both 
by the temperature dependence of release and the suppression of release by the 
metabolic  inhibitors  2-deoxyglucose, iodoacetamide,  and  sodium  azide.  The 
involvement of microtubules  in  histaminase  release  was  suggested  by  the 
studies which demonstrated inhibition of release by colchicine and potentiation 
of release by D20. Granulocyte histaminase release appeared noncytotoxic since 
release was not accompanied  by either the concomitant uptake of trypan blue or 
the release of the  cytoplasmic enzyme LDH.  Preliminary studies  suggest a 
similar pattern of release of histaminase from human eosinophils stimulated 
with opsonized zymosan, latex particle, or calcium ionophore. 
These results suggest a noncytotoxic stimulus-coupled release of histaminase 
from human granulocytes. Weissmann et al.  (4) have shown that lysosomal 
enzymes (beta glucuronidase and acid phosphatase) and lysozyme were released 
from granulocytes challenged with zymosan, while Goldstein et al.  (5) demon- 
strated that lysozyme was released by ionophore. The potentiation of histami- 
nase release by opsonization of particles was in agreement with the studies of 
others  (4,  12). Opsonized  zymosan-induced histaminase  release  approached 
100% during optimal particle contact, while beta glucuronidase release reached 
only 25%. Moreover, histaminase release induced by opsonized zymosan, oc- 
curred at particle to cell ratios which resulted in only minimal beta glucuroni- 
dase  release.  Ionophore stimulated a  dose-dependent release of granulocyte 
histaminase which approached 100% at concentrations of ionophore that barely 
released beta glucuronidase. 
It has been suggested that differences in granulocyte enzyme release may 
relate to the physical and chemical properties of the limiting membranes of the 
particular class of granule (28). Although histaminase has been localized to the 
granule-rich fraction of human granulocytes, specific granule localization is not 
yet known.  Lysozyme-containing granules in the human granulocyte appar- 
ently have been  shown  to  be  distinct  from the  azurophilic granules which 
contain lysosomal enzymes, such as beta glucuronidase and myeloperoxidase 
(30). The release experiments suggest that histaminase may therefore reside in 
a granule distinct from the lysosomes. 
The augmentation of opsonized zymosan-induced histaminase release by CB 
was in agreement with the potentiation by CB of release of granulocyte  enzymes 
as noted by others (5, 12). Goldstein et al. have suggested that recognition of C5a 
may be important for CB-induced release of lysosomal enzymes and lysozyme 
(31). 
The modulation of allergic reactions by leukocyte  products has received recent 
support. Wasserman et al. have shown that eosinophil arylsulfatase inactivates 
SRS-A  (32) and  Goetzl et al.  demonstrated that phagocytosis by guinea pig 
eosinophils of starch particles resulted in the release of arylsulfatase (33). Kater ROBERT  S. ZEIGER~  FRANK  J. TWAROGy  AND  HARVEY  R. COLTEN  1059 
et al. (34) have demonstrated that eosinophils possess a phospholipase D which 
can inactivate mast cell and basophil platelet-aggregating factor. Studies by 
Hubscher (35) suggested that prostaglandins derived from human eosinophils 
are capable of inhibiting antigen-triggered histamine release. The presence of a 
histaminase catabolic enzyme system in  human neutrophils and  eosinophils 
which  is  released  in  response  to  appropriate  stimuli  provides  evidence that 
granulocytes may modulate hypersensitivity reactions by inactivating hista- 
mine at sites of inflammation. 
Summary 
Histaminase (EC-1.4.3.6),  one of the two catabolic enzymes for histamine, is 
contained in human granulocytes. Opsonized zymosan or the calcium ionophore 
A-23187 induce a  dose-dependent release of histaminase from human granulo- 
cytes in vitro. Release is completed within 30 min, is temperature dependent, 
and requires divalent cations. Opsonized zymosan-induced histaminase release 
was maximal in the presence of both calcium and magnesium, whereas iono- 
phore release was magnesium independent. The total cellular content ofhistam- 
inase could be released by both opsonized zymosan and ionophore. In contrast, 
only 25% of the cellular beta glucuronidase, a  lysosomal enzyme, was released 
aKer maximal stimulation with opsonized zymosan; there was minimal release 
of  beta glucuronidase with ionophore. Zymosan- and ionophore-induced histami- 
nase release was inhibited by agents that are presumed to interfere with cell 
metabolism and disrupt microtubules. Human granulocytes therefore may mod- 
ulate the effect of histamine by releasing histaminase at a site of inflammation. 
Studies of granulocyte histaminase release  in  vitro may also provide a  new 
model to explore granulocyte function and secretion. 
The authors wish to thank Mr. David Yurdin for his expert technical assistance throughout this 
investigation. 
Received for publication  10 June 1976. 
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